Electrophysiological mechanism of enhanced susceptibility of hypertrophied heart to acquired Torsade de Pointes arrhythmias - Tridimensional mapping of activation and recovery patterns

被引:68
作者
Kozhevnikov, DO
Yamamoto, K
Robotis, D
Restivo, M
El-Sherif, N
机构
[1] SUNY Hlth Sci Ctr, Div Cardiol, Dept Med, Brooklyn, NY 11203 USA
[2] NY Harbor Hlth Care Syst, Brooklyn, NY USA
关键词
hypertrophy; torsade de pointes; long-QT syndrome; antiarrhythmia agents;
D O I
10.1161/hc0902.104711
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Cardiac hypertrophy is associated with increased incidence of sudden death and susceptibility to proarrhythmic effects of antiarrhythmic agents. However, the in vivo electrophysiologic mechanism of the arrhythmias has not been investigated in detail. Methods and Results-Dose-dependent susceptibility to Torsade de Pointes (TdP) by class III drug dofetilide, 3, 10, and 30 mug/kg, was compared in 6 control dogs (C) and in 5 dogs 6 to 8 weeks after induction of complete atrioventricular block (AVB) that resulted in ventricular hypertrophy (H). Tridimensional ventricular activation and repolarization (R) patterns were simultaneously analyzed from unipolar extracellular electrograms, and local R was measured from activation recovery intervals. Both R and transmural dispersion of R (TDR) were significantly greater in dogs with H compared,with C. Dofetilide resulted in cycle length-dependent and c dose-dependent prolongation of R. which was more marked in left ventricular endocardium/midmyocardium compared with epicardium. resulting in significant increase of TDR. These changes were more accentuated in dogs with H compared with C. All 5 dogs with H developed UP at a dose of 3 to 10 mug/kg, whereas only 1 of 6 C dogs developed TO at 30 mug/kg. UP was initiated by subendocardial focal activity that infringed on TDR, resulting in functional conduction block and reentrant excitation. Conclusions-Enhanced susceptibility of hypertrophied heart to class III drugs is attributable to baseline increased TDR and greater dose-related accentuation of TDR compared with nonhypertrophied heart. This provides the electrophysiologic substrate for drug-induced TdP.
引用
收藏
页码:1128 / 1134
页数:7
相关论文
共 18 条
[11]   CONTRACTILE STATE OF HYPERTROPHIED LEFT-VENTRICLE IN LONG-STANDING VOLUME OVERLOAD [J].
NEWMAN, WH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1978, 234 (01) :H88-H93
[12]   DOFETILIDE, A NOVEL CLASS-III ANTIARRHYTHMIC AGENT [J].
RASMUSSEN, HS ;
ALLEN, MJ ;
BLACKBURN, KJ ;
BUTROUS, GS ;
DALRYMPLE, HW .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 :S96-S105
[13]   ESTIMATING CARDIAC TRANSMEMBRANE ACTIVATION AND RECOVERY TIMES FROM UNIPOLAR AND BIPOLAR EXTRACELLULAR ELECTROGRAMS - A SIMULATION STUDY [J].
STEINHAUS, BM .
CIRCULATION RESEARCH, 1989, 64 (03) :449-462
[14]   Dofetilide in patients with congestive heart failure and left ventricular dysfunction [J].
Torp-Pedersen, C ;
Moller, M ;
Bloch-Thomsen, PE ;
Kober, L ;
Sandoe, E ;
Egstrup, K ;
Agner, E ;
Carlsen, J ;
Videbæk, J ;
Marchant, B ;
Camm, AJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (12) :857-865
[15]   Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired Torsade de Pointes arrhythmias - A comparison between almokalant and d-sotalol using the dog as its own control [J].
Verduyn, SC ;
Vos, MA ;
vanderZande, J ;
Kulcsar, A ;
Wellens, HJJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (06) :1575-1584
[16]   Cellular basis of biventricular hypertrophy and arrhythmogenesis in dogs with chronic complete atrioventricular block and acquired Torsade de Pointes [J].
Volders, PGA ;
Sipido, KR ;
Vos, MA ;
Kulcsár, A ;
Verduyn, SC ;
Wellens, HJJ .
CIRCULATION, 1998, 98 (11) :1136-1147
[17]   REPRODUCIBLE INDUCTION OF EARLY AFTERDEPOLARIZATIONS AND TORSADE-DE-POINTES ARRHYTHMIAS BY D-SOTALOL AND PACING IN DOGS WITH CHRONIC ATRIOVENTRICULAR-BLOCK [J].
VOS, MA ;
VERDUYN, SC ;
GORGELS, APM ;
LIPCSEI, GC ;
WELLENS, HJJ .
CIRCULATION, 1995, 91 (03) :864-872
[18]  
Yamamoto K, 2001, J AM COLL CARDIOL, V37, p311S